 "coronavirus, covid-19, tests")
The World Health Organization on Friday issued an emergency use listing to Covovax, Serum Institute of India's version of Novavax Inc's COVID-19 vaccine.
The agency said that Novovax's own vaccine is currently under assessment by the European Medicines Agency, and it will complete its own assessment of this vaccine once the EMA has issued its recommendation.
“Even with new variants emerging, vaccines remain one of the most effective tools to protect people against serious illness and death from SARS-COV-2,” said Dr Mariângela Simão, WHO Assistant-Director General for Access to Medicines and Health Products. "This listing aims to increase access particularly
